These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6669208)

  • 1. [In vitro cytotoxic activity of peripheral blood lymphocytes in patients with multiple sclerosis. Preliminary report].
    Czernicki J; Pacześniak J; Maciejek Z
    Neurol Neurochir Pol; 1983; 17(6):633-8. PubMed ID: 6669208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels].
    Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of adherent cells in supporting natural cytotoxicity reactions].
    Sorokin AM; Chenëv SB; Koval'chuk LV
    Biull Eksp Biol Med; 1989 Sep; 108(9):322-5. PubMed ID: 2611391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
    Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suppressor cell activity in multiple sclerosis and other nervous system diseases. Preliminary report].
    Czernicki J; Offierska M; Maciejek Z; Tchórzewski H; Chmielewski H
    Neurol Neurochir Pol; 1981; 15(3):283-9. PubMed ID: 6458774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.
    Uchida A; Maida EM; Lenzhofer R; Micksche M
    Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S; Møller-Larsen A; Pedersen E
    Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
    J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-lymphocytes with a receptor for the immunoglobulin Fc fragment in the blood of multiple sclerosis patients].
    Czernicki J; Rzetelski B
    Neurol Neurochir Pol; 1981; 15(5-6):559-64. PubMed ID: 6210849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal T cell subsets and lymphocyte activity in multiple sclerosis.
    Albala MM; Davignon D; Fast LD; Clark DD
    Clin Exp Immunol; 1985 Sep; 61(3):542-7. PubMed ID: 3878242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis.
    Santoli D; Hall W; Kastrukoff L; Lisak RP; Perussia B; Trinchieri G; Koprowski H
    J Immunol; 1981 Apr; 126(4):1274-8. PubMed ID: 6162885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cellular immune response of bladder tumor patients: effects of aging on cytotoxic activity against T24].
    Kato M
    Hinyokika Kiyo; 1988 Aug; 34(8):1363-9. PubMed ID: 3195404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytotoxic activity of K-lymphocytes (killer cells) in Hodgkin's disease].
    Górska B; Konopka L; Seyfried H; Pawelski S
    Pol Tyg Lek; 1980 Aug; 35(33):1249-51. PubMed ID: 7433209
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regulation of the activity of human natural killer cells by autologous interferon].
    Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
    Braakman E; van Tunen A; Meager A; Lucas CJ
    Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of natural killer cells (NK) in patients with atopic diseases of the respiratory system].
    Kruszewski J; Janiak M; Romanowska E; Maleszka P
    Pneumonol Alergol Pol; 1991; 59(1-2):38-42. PubMed ID: 1843885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct lymphocyte subset displaying spontaneous cytotoxic activity against chicken erythrocytes. Morphological, cytochemical, immunocytochemical and functional characterization.
    Magyarlaki T; Szekeres J; Matolcsy A
    Acta Morphol Hung; 1991; 39(1):21-32. PubMed ID: 1684691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.